continuing medical education

intended audience

This activity was developed for neonatologists, nurse practitioners, nurses, and other health care providers working with low birth weight babies.

learning objectives

Upon completion of this activity, participants should be better able to:

Describe the epidemiology, pathophysiology and clinical identification of PDA

Evaluate the efficacy and safety of various treatment options supported by

the scientific literature

Assess the role and clinical experience and issues with cyclooxygenase inhibitors,

including IV ibuprofen lysine as compared with IV indomethacin

Utilize appropriate treatment strategies to optimize outcomes

accreditation and certification

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and Akita Biomedical Consulting. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Creditstm. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners. Provider #040207. The Annenberg Center designates this program for 1 contact hour of continuing education.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 1 contact hour may be earned for successful completion of this activity.

There is no charge for this activity. Statements of Credit will be provided by mail following activity participation, and upon completion and return of the evaluation form to the Annenberg Center for Health Sciences. Please allow 4-6 weeks for the delivery of your statement.

disclosure

It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

The following faculty have no significant relationship to disclose:

The faculty for this activity have disclosed that there will be no discussion about the use of products for non-FDA approved applications.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage the practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

If you need reasonable, special accommodations or have questions about access to any of our activities, please contact Pam Davidson by phone at 800-321-3690 by fax at 760-773-4550, or by e-mail at .
 

This activity is supported by an independent educational grant from Ovation Pharmaceuticals, Inc.

This activity is an enduring material and consists of a web activity. Successful completion is achieved by reading and/or viewing the materials, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 1 hour.

This activity was originally released in March 2008 and is eligible for credit through February 2009.